Results 261 to 270 of about 60,513 (321)

Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation

, 2001
Z Li, H. Joachim Deeg
openalex   +1 more source

Impact of Early-Onset or Worsening Anemia in Patients with Myelofibrosis Treated with Ruxolitinib: A post hoc Analysis of the JUMP Study.

Acta Haematol
Al-Ali HK, Guglielmelli P, Harrison CN, Mesa RA, Hamer-Maansson JE, Braunstein E, Gupta V.   +6 more
europepmc   +1 more source

Prevalence of Arterial Stiffness Determined by Cardio-Ankle Vascular Index in Myeloproliferative Neoplasms. [PDF]

J Clin Med
Jindaluang T, Rattarittamrong E, Chai-Adisaksopha C, Piriyakhuntorn P, Norasetthada L, Tantiworawit A, Rattanathammethee T, Hantrakool S, Hantrakun N, Punnachet T, Niprapan P, Gunaparn S, Phrommintikul A.   +12 more
europepmc   +1 more source

4. Myelofibrosis

Nihon Naika Gakkai Zasshi, 2007
openaire   +3 more sources

Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Wang L, Li J, Arbitman L, Zhang H, Shao H, Martin M, Moscinski L, Song J.   +7 more
europepmc   +1 more source

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis [PDF]

Boque, Concepción, Gómez, Montse, Hernández Boluda, Juan Carlos, Luño Fernández, Elisa, Pereira, Arturo   +4 more
core   +1 more source

Cytokine Landscapes, Immune Dysregulation, and Treatment Perspectives in Philadelphia-Negative Myeloproliferative Neoplasms: A Narrative Review. [PDF]

J Clin Med
Todor SB, Mihaila RG.
europepmc   +1 more source

Actinium-225-PSMA-617 treatment in a patient with advanced prostate cancer causes secondary myelofibrosis: a case report and literature review. [PDF]

Front Med (Lausanne)
Wang Z, Tang W, Liu M, Xie Z, Li Y, Du J, Wu T.   +6 more
europepmc   +1 more source

A Retrospective Study of 19 Cases of Canine Myelofibrosis

, 2002
Douglas J. Weiss, Stephanie A. Smith
openalex   +1 more source

ZRSR2 loss causes aberrant splicing in JAK2^V617F-driven myeloproliferative neoplasm but is not sufficient to drive disease progression. [PDF]

Hemasphere
Zhang R, Straube J, Janardhanan Y, Haldar R, Cooper L, Hayes N, Laurore C, Kim CJ, Luskin MR, Lindsley RC, Stahl M, Mullally A, Marneth AE, Bywater M, Lane SW.   +14 more
europepmc   +1 more source